Zinc Sulfate Eye Solution |
Eye-Sed |
Clinical Trial: Zinc Deficiency in HIV - 1
This study is currently recruiting patients.
Verified by National Institute on Drug Abuse (NIDA) August 2005
Purpose
| Condition | Intervention |
|---|---|
| HIV alcohol & drug use zinc zinc deficiency | Drug: zinc |
MedlinePlus related topics: Nutrition
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Zinc Therapy in Zinc Deficient HIV+ Drug Users
Expected Total Enrollment: 600
Study start: June 2001
Eligibility
Inclusion Criteria:
- HIV infection
Drug User
Plasma zinc level >0.35mcg and <0.75mcg/ml
Age 18 and over
Signature on consent for HIV antibody testing, and a general
medical information form
Willingness to participate in a clinical trial of 30 months duration
Exclusion Criteria:
- Participation in an another clinical trial
Plasma selenium levels <85mcg/L
Pregnancy or intent to become pregnant
Location and Contact Information
Florida
Camillus House, Miami, Florida, 33132, United States; Recruiting
Marianna K Baum, Ph.D., Principal Investigator, Florida International University
More Information
Last Updated: September 7, 2005
Record first received: September 6, 2005
ClinicalTrials.gov Identifier: NCT00149552
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Eye-Sed (Drug Digest)
- Zinc Sulfate Eye Solution (Drug Digest)

Not Signed In -


